Introducing the Anti-CD340/ERBB2/HER2 scFV Antibody (SAA2245) – the latest addition to our biotech product line. This highly specialized antibody is designed to specifically target and bind to the CD340/ERBB2/HER2 protein, making it a valuable tool for research in the fields of oncology and immunology.
Biological Function:
The CD340/ERBB2/HER2 protein, also known as human epidermal growth factor receptor 2, is a transmembrane receptor that plays a key role in cell growth and survival. Overexpression of this protein has been linked to various types of cancer, making it an important target for therapeutic and research purposes.
Main Applications:
The Anti-CD340/ERBB2/HER2 scFV Antibody (SAA2245) can be used in a variety of applications, including:
1. Cancer Research: This antibody can be used to study the role of CD340/ERBB2/HER2 in various types of cancer. It can also be used in drug development and screening for potential anti-cancer therapies.
2. Immunohistochemistry (IHC): The high specificity of this antibody makes it an ideal tool for IHC, allowing for the detection and localization of CD340/ERBB2/HER2 in tissue samples.
3. Flow Cytometry: The Anti-CD340/ERBB2/HER2 scFV Antibody (SAA2245) can be used in flow cytometry experiments to identify and isolate cells expressing high levels of CD340/ERBB2/HER2.
Experimental Use Cases:
1. Investigating HER2-positive Breast Cancer: The overexpression of HER2 in breast cancer is associated with a more aggressive form of the disease. Researchers can use this antibody to study the mechanisms of HER2-positive breast cancer and develop targeted therapies.
2. Assessing HER2 Expression in Gastric Cancer: HER2 is also overexpressed in a subset of gastric cancers. This antibody can be used in IHC to determine the level of HER2 expression in gastric cancer samples, aiding in diagnosis and treatment decisions.
3. Targeted Therapy for Ovarian Cancer: Ovarian cancer cells often overexpress HER2, making them susceptible to targeted therapy using this antibody. Researchers can use this antibody to develop and test new treatments for this type of cancer.
In conclusion, the Anti-CD340/ERBB2/HER2 scFV Antibody (SAA2245) is a highly specific and versatile tool for studying the CD340/ERBB2/HER2 protein in various research areas. With its wide range of applications and potential use cases, this antibody is a valuable asset for any biotech laboratory. Order now and take your research to the next level.
There are no reviews yet.